E-LIB Suche - Ergebnisse für: McLaurin, Eugene

1

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Pers..:

Shettle, Lee ; McLaurin, Eugene ; Martel, Joseph..
Clinical Ophthalmology. 16 (2022) - p. 2167-2177 , 2022

Link: https://doi.org/10.2147/..

2

A Water-free 0.1% Cyclosporine A Solution for Treatment of ..:

Sheppard, John D. ; Wirta, David L. ; McLaurin, Eugene...
Cornea. 40 (2021) 10 - p. 1290-1297 , 2021

Link: https://doi.org/10.1097/..

3

Repository Corticotropin Injection (Acthar® Gel) for Refrac..:

Wirta, David ; McLaurin, Eugene ; Ousler, George...
Ophthalmology and Therapy. 10 (2021) 4 - p. 1077-1092 , 2021

Link: https://doi.org/10.1007/..

4

Efficacy and Safety of Topical Cyclosporine in Dry Eye Subj..:

Ora Inc., Andover, MA, USA ; Ora Inc., Andover, MA, USA ; Carl Zeiss Meditec Inc, Dublin, CA, USA...
US Ophthalmic Review. 12 (2019) 2 - p. 88 , 2019

Link: https://doi.org/10.17925..

5

Low‐dose brimonidine for relief of ocular redness: integrat..:

Ackerman, Stacey L ; Torkildsen, Gail L ; Mclaurin, Eugene.
Clinical and Experimental Optometry. 102 (2019) 2 - p. 131-139 , 2019

Link: https://doi.org/10.1111/..

6

Two Phase 3 Clinical Trials Comparing the Safety and Effica..:

Serle, Janet B. ; Katz, L. Jay ; McLaurin, Eugene...
American Journal of Ophthalmology. 186 (2018) - p. 116-127 , 2018

Link: https://doi.org/10.1016/..

7

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocu..:

McLaurin, Eugene ; Cavet, Megan E. ; Gomes, Paul J..
Optometry and Vision Science. 95 (2018) 3 - p. 264-271 , 2018

Link: https://doi.org/10.1097/..

8

Pooled analysis of two studies evaluating efficacy and safe..:

McLaurin, Eugene ; Bergmann, Mark ; Narvekar, Abhijit...
Clinical Ophthalmology. 11 (2017) - p. 1089-1097 , 2017

Link: https://doi.org/10.2147/..

9

Effect of alcaftadine 0.25% on ocular itch associated with ..:

Ciolino, Joseph B ; McLaurin, Eugene ; Marsico, Nicholas...
Clinical Ophthalmology. , 2015

Link: https://doi.org/10.2147/..

10

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With ..:

Panarelli, Joseph F. ; Bowden, Eileen C. ; Tepedino, Michael E....
Journal of Glaucoma. 32 (2023) 12 - p. 999-1005 , 2023

Link: https://doi.org/10.1097/..

11

A randomized, vehicle-controlled, Phase 2b study of two con..:

Wirta, David L. ; Senchyna, Michelle ; Lewis, Amber E....
The Ocular Surface. 26 (2022) - p. 166-173 , 2022

Link: https://doi.org/10.1016/..

12

Phase 3 Randomized Study of Efficacy and Safety of a Dexame..:

McLaurin, Eugene B. ; Evans, David ; Repke, Carolyn S....
American Journal of Ophthalmology. 229 (2021) - p. 288-300 , 2021

Link: https://doi.org/10.1016/..

13

Plasma Pharmacokinetic Parameters of Dexamethasone Followin..:

Blizzard, Charles ; McLaurin, Eugene B ; Driscoll, Arthur...
Clinical Ophthalmology. 15 (2021) - p. 2055-2061 , 2021

Link: https://doi.org/10.2147/..

14

Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of ..:

McLaurin, Eugene B. ; Marsico, Nicholas P. ; Ciolino, Joseph B....
Journal of Allergy and Clinical Immunology. 133 (2014) 2 - p. AB278 , 2014

Link: https://doi.org/10.1016/..

15

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadin..:

McLaurin, Eugene B. ; Marsico, Nicholas P. ; Ackerman, Stacey L....
Advances in Therapy. 31 (2014) 10 - p. 1059-1071 , 2014

Link: https://doi.org/10.1007/..